The National Health and Medical Research Council (NHMRC) awarded 14 RMH staff as part of its latest round of funding for new innovations in healthcare.
The NHMRC Investigator grants provide a five-year fellowship and research support for researchers across all stages of their careers with the aim of fostering new opportunities, innovation and creative research.
Professor Leonid Churilov was also made a fellow of the 2022 Australian Academy of Health and Medical Sciences. A biostatistician, Professor Churilov was recognised for leading a complex and comprehensive design and analysis of acute and recovery stroke trials that have resulted in global changes in clinical practice.
The RMH NHMRC recipients include:
- Professor Mario Alvarez-Jimenez - Digitally Enhancing Youth Mental Health Services across Australia: cluster RCT of an Adaptive, TaiLored, and behAvioural Science-informed (ATLAS) Implementation Strategy
- Dr Imogen Bell - Harnessing innovative digital technologies to enhance youth mental health care
- Associate Professor Andrew Bivard - Beyond translation: Integrating clinical trials and intelligent health systems for stroke
- Professor Bruce Campbell - Accelerating clot lysis in ischaemic stroke with dornase alfa in an Umbrella Bayesian Optimised Phase 2 trial
- Professor Sue Cotton - The Centre of Research Excellence in Bipolar Disorder (CORE-BD)
- Associate Professor Adam Deane - Dietary protein to improve outcomes from critical illness
- Professor Peter Gibbs - Circulating tumour DNA informed management of early-stage colorectal cancer and pancreas cancer
- Professor Stephen Kent - Immunity, Vaccines and Therapeutics for pandemic viruses
- Professor James McCarthy - Translational studies in infectious disease
- Dr Felix Ng - Microvascular dysfunction in acute ischaemic stroke: The next frontier in stroke reperfusion
- Associate Professor Piero Perucca - Translating Epilepsy Genetics Advances into Improved Patient Care
- Dr Aswin Ratheesh - Bipolar Early intervention using New Digital technologies: a hybrid effectiveness-implementation trial of a multi-component model of evidence-based care
- Professor Andrew Wei - Early intervention for therapeutic benefit in AML: a national program of clinical trials
We provide a media service from 6am to 10pm each day. Journalists are welcome to contact our media advisor on-call via the RMH Switchboard on (03) 9342 7000.
During business hours, journalists can email mh-communications@mh.org.au. We do not respond to emails outside business hours.